April 6, 2012
An interesting debate is in progress after an FDA meeting to consider making an 10 day emergency kit of the antibiotic, doxycycline, available for the US population to have at home in the event of a bioterrorism attack using Anthrax.
From Bloomberg News published April 3, 2012
Making anthrax-antidote kits available to the 114 million households in the U.S. in case of a bioterrorism attack may lead to misuse of the medicines and stir up public fears, regulatory advisers said.
“People may infer an anthrax attack is imminent,” Thomas Moore, chairman of a Food and Drug Administration advisory committee, said in an interview yesterday after a meeting on the subject. “It may have an adverse impact on doxycycline,” the antibiotic that was hoarded after the Sept. 11, 2001, terror attacks, he said.
The FDA met with panels of scientists and academics to consider whether kits containing a 10-day supply of doxycycline should be available for all Americans to store in their homes in preparation for a bioterrorism attack. A branch of the Health and Human Services Department said it wants to start with 10 million first responders and their families before expanding it to the rest of the population.